These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10026332)

  • 1. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia.
    Cramp ME; Carucci P; Rossol S; Chokshi S; Maertens G; Williams R; Naoumov NV
    Gut; 1999 Mar; 44(3):424-9. PubMed ID: 10026332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome.
    Löhr HF; Gerken G; Roth M; Weyer S; Schlaak JF; Meyer zum Büschenfelde KH
    J Hepatol; 1998 Oct; 29(4):524-32. PubMed ID: 9824260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of hepatitis C virus specific immune responses in anti-HCV positive patients without hepatitis C viremia.
    Yao P; Hu X; Hu D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):227-30. PubMed ID: 11498684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.
    Hempel G; Galle PR; Löhr HF
    J Med Virol; 2001 Jul; 64(3):340-9. PubMed ID: 11424124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.
    Takaki A; Wiese M; Maertens G; Depla E; Seifert U; Liebetrau A; Miller JL; Manns MP; Rehermann B
    Nat Med; 2000 May; 6(5):578-82. PubMed ID: 10802716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
    Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV.
    Chu CM; Yeh CT; Sheen IS; Liaw YF
    Gut; 2002 Jul; 51(1):95-9. PubMed ID: 12077099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
    Alvarez-Lajonchere L; Shoukry NH; Grá B; Amador-Cañizares Y; Helle F; Bédard N; Guerra I; Drouin C; Dubuisson J; González-Horta EE; Martínez G; Marante J; Cinza Z; Castellanos M; Dueñas-Carrera S
    J Viral Hepat; 2009 Mar; 16(3):156-67. PubMed ID: 19017255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.
    Raziorrouh B; Sacher K; Tawar RG; Emmerich F; Neumann-Haefelin C; Baumert TF; Thimme R; Boettler T
    Gastroenterology; 2016 Mar; 150(3):696-706.e3. PubMed ID: 26584604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.
    Hultgren C; Milich DR; Weiland O; Sällberg M
    J Gen Virol; 1998 Oct; 79 ( Pt 10)():2381-91. PubMed ID: 9780043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of successful immune responses in persons infected with hepatitis C virus.
    Lechner F; Wong DK; Dunbar PR; Chapman R; Chung RT; Dohrenwend P; Robbins G; Phillips R; Klenerman P; Walker BD
    J Exp Med; 2000 May; 191(9):1499-512. PubMed ID: 10790425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
    Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
    J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.
    Zampino R; Marrone A; Durante Mangoni E; Santarpia L; Sica A; Tripodi MF; Utili R; Ruggiero G; Adinolfi LE
    J Med Virol; 2004 May; 73(1):33-7. PubMed ID: 15042645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Núñez-Roldán A; Aguilar-Reina J
    J Viral Hepat; 2011 Oct; 18(10):e541-9. PubMed ID: 21914075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels.
    Rico MA; Quiroga JA; Subirá D; Garcia E; Castañón S; Sällberg M; Leroux-Roels G; Weiland O; Pardo M; Carreño V
    J Hepatol; 2002 Mar; 36(3):408-16. PubMed ID: 11867186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
    J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response.
    Meyer MF; Lehmann M; Cornberg M; Wiegand J; Manns MP; Klade C; Wedemeyer H
    Virol J; 2007 Jun; 4():58. PubMed ID: 17562015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.